Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transposition of Internal Limiting Membrane in the Treatment of Macular Holes. A Descriptive Pilot Study

NCT02946372 is registered in ClinicalTrials.gov with Groupe Hospitalier de la Region de Mulhouse et Sud Alsace as lead sponsor.

NCT NCT02946372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02946372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transposition of Internal Limiting Membrane in the Treatment of Macular Holes. A Descriptive Pilot Study
Lead sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Phase
Not applicable
Overall status
Terminated
Start date
November 30, 2016
Completion date
June 30, 2017
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinal perforations